Reply to comment by Carratù P, et al. on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial

Katrin E. Hostettler; Martin H. Brutsche

doi:10.4414/smw.2019.20133

Author reply to technical comment

Vol. 149 No. 3940 (2019)

Reply to comment by Carratù P, et al. on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial

Katrin E. Hostettler
Martin H. Brutsche

DOI: https://doi.org/10.4414/smw.2019.20133
Cite this as:: Swiss Med Wkly. 2019;149:w20133
Published: 30.09.2019

References

Carratù P, Dragonieri S, Resta O. Comment on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial. Swiss Med Wkly. 2019;149:w20132. doi:https://doi.org/10.4414/smw.2019.20132
Hostettler K, Baty F, Kleiner R, Junker L, Tamm M, Brutsche M. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial. Swiss Med Wkly. 2018;148:w14677. doi:.https://doi.org/10.4414/smw.2018.14677
Sofia M, Mormile M, Faraone S, Alifano M, Carratù P, Carratù L. Endothelin-1 excretion in urine in active pulmonary sarcoidosis and in other interstitial lung diseases. Sarcoidosis. 1995;12(2):118–23.

Publication image

How to Cite

1.

Hostettler KE, Brutsche MH. Reply to comment by Carratù P, et al. on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial. Swiss Med Wkly [Internet]. 2019 Sep. 30 [cited 2024 Nov. 24];149(3940):w20133. Available from: https://smw.ch/index.php/smw/article/view/2679

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Daniel P. Franzen, Martin Brutsche, Jakob Nilsson, Christian Böni, Cécile Daccord, Oliver Distler, Dieter Elsener, Manuela Funke-Chambour, Christiane Gruner, Helen Hayward-Könnecke, Katrin E. Hostettler, Thomas Kündig, Camillo Ribi, Jörg D. Seebach, Harald Seeger, Bart Vrugt, Antonios G. A. Kolios, Sarcoidosis – a multisystem disease , Swiss Medical Weekly: Vol. 152 No. 0102 (2022)
Mihaela Sava, Gregor Sommer, Thomas Daikeler, Anne-Kathrin Woischnig, Aurélien E. Martinez, Karoline Leuzinger, Hans H. Hirsch, Tobias E. Erlanger, Andrea Wiencierz, Stefano Bassetti, Michael Tamm, Sarah Tschudin-Sutter, Marcel Stoeckle, Hans Pargger, Martin Siegemund, Renate Boss, Gert Zimmer, Diem-Lan Vu, Laurent Kaiser, Salome Dell-Kuster, Maja Weisser, Manuel Battegay, Katrin E. Hostettler, Nina Khanna, Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab – a single centre cohort study , Swiss Medical Weekly: Vol. 151 No. 3132 (2021)
Christian M. Horvath, Anne-Kathrin Brill, Florent Baty, Martin H. Brutsche, Efficacy of non-invasive intelligent volume assured pressure support (iVAPS) and pressure support ventilation (PSV) in clinical practice , Swiss Medical Weekly: Vol. 151 No. 1920 (2021)
Katrin E. Hostettler, Florent Baty, Rebekka Kleiner, Lilian Junker, Michael Tamm, Martin H. Brutsche, Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial , Swiss Medical Weekly: Vol. 148 No. 4344 (2018)

[1] Carratù P, Dragonieri S, Resta O. Comment on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial. Swiss Med Wkly. 2019;149:w20132. doi:https://doi.org/10.4414/smw.2019.20132

[2] Hostettler K, Baty F, Kleiner R, Junker L, Tamm M, Brutsche M. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial. Swiss Med Wkly. 2018;148:w14677. doi:.https://doi.org/10.4414/smw.2018.14677

[3] Sofia M, Mormile M, Faraone S, Alifano M, Carratù P, Carratù L. Endothelin-1 excretion in urine in active pulmonary sarcoidosis and in other interstitial lung diseases. Sarcoidosis. 1995;12(2):118–23.